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To the Editor, 
I read with interest the recent case report by Drs Renfree and Dell (1). 
The specific limb and scalp defects observed in Adams-Oliver syndrome (AOS) cover a wide range of 
clinical severity such that the disorder is often not diagnosed on first presentation. Elucidating the 
underlying molecular mechanisms is therefore critical to our understanding of the manifestation and 
progression of this disorder, in turn providing an opportunity for improved patient diagnosis and 
clinical management. 
The article stated that no gene has been identified for this disorder. On the contrary, there has been 
considerable progress in our understanding of the biological pathways important in this condition 
after the identification of six genes since 2011 (2). Of the genes reported to date, ARHGAP31 and 
DOCK6 are regulators of the Rho GTPases Cdc42 and Rac1, while RBPJ, EOGT, NOTCH and DLL4 are 
involved in the Notch signalling pathway. The mode of inheritance may be either autosomal 
dominant or autosomal recessive, although a number of cases have been shown to be caused by de 
novo mutation (3). Through assessment of specific clinical features, some genotype-phenotype 
correlations are starting to emerge, but these are limited by small sample size. Of note, autosomal 
recessive mutations in DOCK6 are associated with an increased risk of neurological and 
ophthalmological defects (4), and our recent findings indicate a higher proportion of cardiovascular 
defects in AOS patients harbouring autosomal dominant NOTCH1 mutations (5). 
In conclusion, we and others have identified four autosomal dominant and two autosomal recessive 
genes, which highlight Rho dysregulation and aberrant Notch signalling as consistent risk factors in 
AOS pathogenesis. These genes account for ~50% of AOS cases, providing the option of genetic 
counselling and improved clinical care for a considerable proportion of patients affected with this 
condition, while also indicating there are likely to be a considerable number of genes yet to be found. 
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